Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


22.05.2017

2 Alzheimers Dement
1 Biochemistry
1 BMC Neurol
1 Exp Neurol
1 Int J Neurosci
19 J Alzheimers Dis
1 J Biol Chem
3 J Neural Transm (Vienna)
2 J Neurochem
1 J Neurol Neurosurg Psychiatry
1 Nat Rev Neurosci
3 Neurology
1 Neuroreport
1 Rev Neurol (Paris)


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimers Dement

  1. BROWN BM, Sohrabi HR, Taddei K, Gardener SL, et al
    Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2017 May 11. pii: S1552-5260(17)30147.
    PubMed     Text format     Abstract available

  2. FEART C, Helmer C, Merle B, Herrmann FR, et al
    Associations of lower vitamin D concentrations with cognitive decline and long-term risk of dementia and Alzheimer's disease in older adults.
    Alzheimers Dement. 2017 May 9. pii: S1552-5260(17)30138.
    PubMed     Text format     Abstract available


    Biochemistry

  3. MIHAILOVIC MK, Chen A, Gonzalez-Rivera JC, Contreras LM, et al
    Defective Ribonucleoproteins, Mistakes in RNA Processing, and Diseases.
    Biochemistry. 2017;56:1367-1382.
    PubMed     Text format     Abstract available


    BMC Neurol

  4. KANETA T, Katsuse O, Hirano T, Ogawa M, et al
    Voxel-wise correlations between cognition and cerebral blood flow using arterial spin-labeled perfusion MRI in patients with Alzheimer's disease: a cross-sectional study.
    BMC Neurol. 2017;17:91.
    PubMed     Text format     Abstract available


    Exp Neurol

  5. HSU WJ, Wildburger N, Haidacher SJ, Nenov MN, et al
    PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease.
    Exp Neurol. 2017 May 15. pii: S0014-4886(17)30122.
    PubMed     Text format     Abstract available


    Int J Neurosci

  6. JOSVIAK ND, Batistela MS, Souza RKM, Wegner NR, et al
    Plasma butyrylcholinesterase activity: a possible biomarker for differential diagnosis between Alzheimer's disease and dementia with Lewy bodies?
    Int J Neurosci. 2017 May 15:1-12. doi: 10.1080/00207454.2017.1329203.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  7. VEGA IE, Cabrera LY, Wygant CM, Velez-Ortiz D, et al
    Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-161261.
    PubMed     Text format     Abstract available

  8. DOUGHERTY RJ, Schultz SA, Kirby TK, Boots EA, et al
    Moderate Physical Activity is Associated with Cerebral Glucose Metabolism in Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-161067.
    PubMed     Text format     Abstract available

  9. CALDERON-GARCIDUENAS L, de la Monte SM
    Apolipoprotein E4, Gender, Body Mass Index, Inflammation, Insulin Resistance, and Air Pollution Interactions: Recipe for Alzheimer's Disease Development in Mexico City Young Females.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-161299.
    PubMed     Text format     Abstract available

  10. MUSAEUS CS, Shafi MM, Santarnecchi E, Herman ST, et al
    Levetiracetam Alters Oscillatory Connectivity in Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-160742.
    PubMed     Text format     Abstract available

  11. BEN JEMAA S, Attia Romdhane N, Bahri-Mrabet A, Jendli A, et al
    An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.
    J Alzheimers Dis. 2017 May 11. doi: 10.3233/JAD-170222.
    PubMed     Text format     Abstract available

  12. CHUNG JK, Plitman E, Nakajima S, Caravaggio F, et al
    Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-170201.
    PubMed     Text format     Abstract available

  13. SNOW WM, Dale R, O'Brien-Moran Z, Buist R, et al
    In Vivo Detection of Gray Matter Neuropathology in the 3xTg Mouse Model of Alzheimer's Disease with Diffusion Tensor Imaging.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-170136.
    PubMed     Text format     Abstract available

  14. JIN WS, Bu XL, Wang YR, Li L, et al
    Reduced Cardiovascular Functions in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 11. doi: 10.3233/JAD-170088.
    PubMed     Text format     Abstract available

  15. ZHU JB, Tan CC, Tan L, Yu JT, et al
    State of Play in Alzheimer's Disease Genetics.
    J Alzheimers Dis. 2017 May 11. doi: 10.3233/JAD-170062.
    PubMed     Text format     Abstract available

  16. EDSBAGGE M, Andreasson U, Ambarki K, Wikkelso C, et al
    Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-161257.
    PubMed     Text format     Abstract available

  17. ORGETA V, Tabet N, Nilforooshan R, Howard R, et al
    Efficacy of Antidepressants for Depression in Alzheimer's Disease: Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-161247.
    PubMed     Text format     Abstract available

  18. TORT-MERINO A, Valech N, Penaloza C, Gronholm-Nyman P, et al
    Early Detection of Learning Difficulties when Confronted with Novel Information in Preclinical Alzheimer's Disease Stage 1.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-161173.
    PubMed     Text format     Abstract available

  19. MANOCHA GD, Ghatak A, Puig KL, Kraner SD, et al
    NFATc2 Modulates Microglial Activation in the AbetaPP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-151203.
    PubMed     Text format     Abstract available

  20. LIU G, Sun JY, Xu M, Yang XY, et al
    SORL1 Variants Show Different Association with Early-Onset and Late-Onset Alzheimer's Disease Risk.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-170005.
    PubMed     Text format     Abstract available

  21. SUN H
    Associations of Spatial Disparities of Alzheimer's Disease Mortality Rates and Soil Selenium, Sulfur Concentrations, and Risk Factors in the United States.
    J Alzheimers Dis. 2017 May 13. doi: 10.3233/JAD-170059.
    PubMed     Text format     Abstract available

  22. SALA I, Illan-Gala I, Alcolea D, Sanchez-Saudinos MB, et al
    Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 13. doi: 10.3233/JAD-170073.
    PubMed     Text format     Abstract available

  23. OLIVEIRA J, Costa M, de Almeida MSC, da Cruz E Silva OAB, et al
    Protein Phosphorylation is a Key Mechanism in Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-170176.
    PubMed     Text format     Abstract available

  24. TANG M, Taghibiglou C
    The Mechanisms of Action of Curcumin in Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-170188.
    PubMed     Text format     Abstract available

  25. SIEDLAK SL, Jiang Y, Huntley ML, Wang L, et al
    TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-170190.
    PubMed     Text format     Abstract available


    J Biol Chem

  26. MORI T, Koyama N, Tan J, Segawa T, et al
    Combination Therapy with Octyl Gallate and Ferulic Acid Improves Cognition and Neurodegeneration in a Transgenic Mouse Model of Alzheimer Disease.
    J Biol Chem. 2017 May 16. pii: jbc.M116.762658. doi: 10.1074/jbc.M116.762658.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  27. LAGARDE J, Sarazin M, Bottlaender M
    In vivo PET imaging of neuroinflammation in Alzheimer's disease.
    J Neural Transm (Vienna). 2017 May 17. doi: 10.1007/s00702-017-1731.
    PubMed     Text format     Abstract available

  28. TAKAHASHI M, Oda Y, Okubo T, Shirayama Y, et al
    Relationships between cognitive impairment on ADAS-cog and regional cerebral blood flow using SPECT in late-onset Alzheimer's disease.
    J Neural Transm (Vienna). 2017 May 16. doi: 10.1007/s00702-017-1734.
    PubMed     Text format     Abstract available

  29. FRANCO BOCANEGRA DK, Nicoll JAR, Boche D
    Innate immunity in Alzheimer's disease: the relevance of animal models?
    J Neural Transm (Vienna). 2017 May 17. doi: 10.1007/s00702-017-1729.
    PubMed     Text format     Abstract available


    J Neurochem

  30. SILMAN I, Sussman JL
    Recent developments in structural studies on acetylcholinesterase.
    J Neurochem. 2017 May 15. doi: 10.1111/jnc.13992.
    PubMed     Text format     Abstract available

  31. COULSON EJ, Bartlett PF
    An exercise path to preventing Alzheimer's disease: An Editorial Highlight on 'Exercise and BDNF reduce Ab production by enhancing alpha-secretase processing of APP'.
    J Neurochem. 2017 May 18. doi: 10.1111/jnc.14038.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  32. AHMED S, Baker I, Thompson S, Husain M, et al
    Utility of testing for apraxia and associated features in dementia.
    J Neurol Neurosurg Psychiatry. 2016;87:1158-1162.
    PubMed     Text format     Abstract available


    Nat Rev Neurosci

  33. KISLER K, Nelson AR, Montagne A, Zlokovic BV, et al
    Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.
    Nat Rev Neurosci. 2017 May 18. doi: 10.1038/nrn.2017.
    PubMed     Text format     Abstract available


    Neurology

  34. GIANNINI LAA, Irwin DJ, McMillan CT, Ash S, et al
    Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia.
    Neurology. 2017 May 17. pii: 10.1212/WNL.0000000000004034.
    PubMed     Text format     Abstract available

  35. SCHULTZ SA, Boots EA, Darst BF, Zetterberg H, et al
    Cardiorespiratory fitness alters the influence of a polygenic risk score on biomarkers of AD.
    Neurology. 2017;88:1650-1658.
    PubMed     Text format     Abstract available

  36. THOMAS AJ, Attems J, Colloby SJ, O'Brien JT, et al
    Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB.
    Neurology. 2017;88:276-283.
    PubMed     Text format     Abstract available


    Neuroreport

  37. GUO Y, Zhao Y, Nan Y, Wang X, et al
    (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
    Neuroreport. 2017 May 17. doi: 10.1097/WNR.0000000000000803.
    PubMed     Text format     Abstract available


    Rev Neurol (Paris)

  38. CRETIN B, Philippi N, Bousiges O, Dibitonto L, et al
    Do we know how to diagnose epilepsy early in Alzheimer's disease?
    Rev Neurol (Paris). 2017 May 10. pii: S0035-3787(16)30031.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: